Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to initial treatment with glucocorticoids in TAFRO syndrome and implications for secondary treatment.
Tominaga R, Umino K, Honda S, Yokoyama D, Noguchi A, Furuki S, Koyama S, Murahashi R, Nakashima H, Hyodo K, Kawaguchi SI, Toda Y, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kanda Y. Tominaga R, et al. Among authors: murahashi r. Int J Hematol. 2025 Jan 29. doi: 10.1007/s12185-025-03933-1. Online ahead of print. Int J Hematol. 2025. PMID: 39881107
Risk-Adapted Letermovir Prophylaxis Based on a Scoring System Predicting a Higher Burden of Cytomegalovirus Exposure After Allogeneic Hematopoietic Cell Transplantation.
Kawamura S, Fujiwara SI, Kimura SI, Takeshita J, Nakasone H, Yoshimura K, Nakata Y, Ishikawa T, Matsuoka A, Meno T, Nakamura Y, Kawamura M, Yoshino N, Misaki Y, Gomyo A, Kusuda M, Murahashi R, Umino K, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kako S, Kanda Y. Kawamura S, et al. Among authors: murahashi r. Transplant Cell Ther. 2025 Jan 17:S2666-6367(25)00911-X. doi: 10.1016/j.jtct.2025.01.883. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39828058
T-ALL presenting with i-TLP-like indolent clinical course with repeated spontaneous regressions.
Toda Y, Ohmine K, Sano N, Nakamura N, Kihara A, Tominaga R, Noguchi A, Yokoyama D, Furuki S, Koyama S, Murahashi R, Nakashima H, Hyodo K, Kawaguchi SI, Umino K, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Fujiwara SI, Kanda Y. Toda Y, et al. Among authors: murahashi r. Pathol Res Pract. 2024 Nov;263:155600. doi: 10.1016/j.prp.2024.155600. Epub 2024 Sep 24. Pathol Res Pract. 2024. PMID: 39326364
Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation.
Nagayama T, Fujiwara SI, Tominaga R, Yokoyama D, Noguchi A, Furuki S, Oyama T, Koyama S, Murahashi R, Nakashima H, Ikeda T, Hyodo K, Kawaguchi SI, Toda Y, Umino K, Minakata D, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kanda Y. Nagayama T, et al. Among authors: murahashi r. Leuk Lymphoma. 2024 Sep;65(9):1350-1356. doi: 10.1080/10428194.2024.2352614. Epub 2024 May 20. Leuk Lymphoma. 2024. PMID: 38767307
Effects of CD34+ cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation.
Oyama T, Fujiwara SI, Tominaga R, Yokoyama D, Noguchi A, Furuki S, Koyama S, Murahashi R, Nakashima H, Hyodo K, Ikeda T, Kawaguchi SI, Toda Y, Nagayama T, Umino K, Minakata D, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Otsuki I, Ohmine K, Kanda Y. Oyama T, et al. Among authors: murahashi r. Clin Transplant. 2024 Apr;38(4):e15313. doi: 10.1111/ctr.15313. Clin Transplant. 2024. PMID: 38581299
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma.
Yamamoto C, Minakata D, Yokoyama D, Furuki S, Noguchi A, Koyama S, Oyama T, Murahashi R, Nakashima H, Ikeda T, Kawaguchi SI, Hyodo K, Toda Y, Ito S, Nagayama T, Umino K, Morita K, Ashizawa M, Ueda M, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kanda Y. Yamamoto C, et al. Among authors: murahashi r. Transplant Cell Ther. 2024 Jan;30(1):118.e1-118.e15. doi: 10.1016/j.jtct.2023.10.001. Epub 2023 Oct 5. Transplant Cell Ther. 2024. PMID: 37802181 Free article.
Early reversal of the lymphocyte-to-monocyte ratio after allogeneic-hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis.
Nagayama T, Fujiwara SI, Tominaga R, Yokoyama D, Noguchi A, Furuki S, Oyama T, Koyama S, Murahashi R, Nakashima H, Ikeda T, Hyodo K, Kawaguchi SI, Toda Y, Umino K, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kanda Y. Nagayama T, et al. Among authors: murahashi r. Clin Transplant. 2023 Dec;37(12):e15116. doi: 10.1111/ctr.15116. Epub 2023 Aug 29. Clin Transplant. 2023. PMID: 37641561
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies.
Minakata D, Fujiwara SI, Yokoyama D, Noguchi A, Aoe S, Oyama T, Koyama S, Murahashi R, Nakashima H, Hyodo K, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Nagayama T, Mashima K, Umino K, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kanda Y. Minakata D, et al. Among authors: murahashi r. Br J Haematol. 2023 Mar;200(6):694-703. doi: 10.1111/bjh.18654. Epub 2023 Jan 20. Br J Haematol. 2023. PMID: 36661264 Review.
Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation.
Fujiwara SI, Murahashi R, Nakashima H, Matsuoka S, Ikeda T, Toda Y, Ito S, Kawaguchi SI, Nagayama T, Umino K, Minakata D, Morita K, Nakano H, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kanda Y. Fujiwara SI, et al. Among authors: murahashi r. Leuk Res. 2022 Oct;121:106951. doi: 10.1016/j.leukres.2022.106951. Epub 2022 Sep 12. Leuk Res. 2022. PMID: 36115066
17 results